The literature research for this Seminar started from standard works and recent reviews.1, 2, 3, 4, 5, 6, 7, 8, 9, 10 We also used our own collections and the library holdings of the Antwerp Institute of Tropical Medicine, and searched PubMed and MEDLINE over the past 10 years for the main topics of this paper with the key words “schistosomes OR schistosomiasis OR schistosoma” PLUS “epidemiology”, “transmission”, “pathology”, “morbidity”, “mortality”, “immunology”, “vaccine”, “treatment”,
SeminarHuman schistosomiasis
Section snippets
Acute pathology
The percutanous penetration of cercariae can provoke a temporary urticarial rash that sometimes persists for days as papulopruriginous lesions, especially after primary infections such as occur in tourists and migrants.15 A similar swimmers' itch is also frequently caused by cercariae of animal trematodes in temperate climate zones.16 Possibly, cercarial dermatitis often goes unrecognised in endemic areas.17
Acute schistosomiasis (Katayama fever) is a systemic hypersensitivity reaction against
Chronic pathology and morbidity
The main lesions in established and chronic infection are due not to the adult worms but to eggs that are trapped in the tissues during the perivesical or peri-intestinal migration or after embolisation in the liver, spleen, lungs, or cerebrospinal system. The eggs secrete proteolytic enzymes that provoke typical eosinophilic inflammatory and granulomatous reactions, which are progressively replaced by fibrotic deposits (figure 4).26 The severity of the symptoms is thus related both to the
Diagnosis
The microscopic examination of excreta remains the gold standard for the diagnosis of schistosomiasis.71 The eggs are easy to detect and identify by microscopy owing to their size and shape, their typical lateral or terminal spine, and the living miracidium (in fresh samples) with mobile cilia and pulsing excretory cells (figure 5). Direct wet slides are not very sensitive; if no eggs are found, concentration methods should be used but even these can miss light infections.72, 73
Urine should be
Treatment
Early treatments against schistosomiasis had severe and even lethal side-effects that had to be weighed against the benefits for the patient.4, 5 The 1970s heralded the advent of effective, safe, and simple drugs.34
Praziquantel, an acylated quinoline-pyrazine that is active against all schistosome species, is now the most widely used. It is mostly marketed as 600 mg tablets, with a recommended standard regimen of 40 mg/kg bodyweight in a single dose.6 The drug acts within 1 h of ingestion by
Immunology
There is longstanding epidemiological and clinical evidence that people living in endemic areas acquire some form of immune resistance after years of exposure.113 In terms of parasite population dynamics, host-related factors such as innate or acquired immunity are likely to have an important role in truncating the enormous reproduction potential of schistosomes to the endemic equilibrium of one.114 The acquisition of effective immunity is difficult to prove, because the decrease in infection
Global burden
Schistosomiasis is highly prevalent, but the associated morbidity is low and variable. Thus, its influence on public health and the priority of control measures have long been debated. The discussion has been revived in light of the renewed resources for the fight against poverty-related diseases and the Global Burden of Disease Study, which attempted to quantify and rank health problems according to disability-adjusted life years (DALY).133 This index is calculated from disease-specific
Control
The aims and strategies of schistosomiasis control have shifted fundamentally over the past few decades, since the introduction of modern schistosomicides, particularly praziquantel. As for other parasitic diseases, transmission control aiming at the intermediate host has been largely replaced by morbidity control through population-based chemotherapy. This strategy allows quick gains, but careful long-term planning is needed to ensure sustainability and progression to the more demanding stages
The way forward
In theory, doctors and other health workers have adequate tools at hand for diagnosis and treatment of most overt cases of schistosomiasis in outpatient or primary care. However, detection of light infections and assessment of their clinical importance remains more difficult. Resistance to praziquantel should be avoided at all costs, and new drugs would be welcome. Improved diagnostic agents and therapeutic strategies are therefore main topics for further applied research on schistosomiasis. A
Search strategy and selection criteria
References (157)
From Katayama to the Dakhla Oasis: the beginning of epidemiology and control of bilharzia
Acta Tropica
(2000)The molecular biology of schistosomes
Trends Parasitol
(2005)- et al.
The snail (Biomphalaria glabrata) genome project
Trends Parasitol
(2006) - et al.
Worm burdens in schistosome infections
Parasitol Today
(1996) - et al.
Imported Katayama fever: clinical and biological features at presentation and during treatment
J Infect
(2006) - et al.
Immunopathology of schistosomiasis mansoni in mice and men
Immunol Today
(2000) - et al.
Changing age incidence and pathological types of schistosoma-associated bladder carcinoma
J Urol
(1995) - et al.
Drugs for the control of parasitic diseases: current status and development in schistosomiasis
Trends Parasitol
(2003) - et al.
Death attributed to kidney failure in communities with endemic urinary schistosomiasis
Lancet
(1970) - et al.
Morbidity, due to schistosomiasis mansoni, and its control in Subsaharan Africa
Parasitol Today
(1991)
Immunopathogenic mechanisms in schistosomiasis: what can be learnt from human studies?
Trends Parasitol
The morbidity of schistosomiasis mansoni in Maniema (Zaire)
Trans R Soc Trop Med Hyg
Severe hepatic fibrosis in Schistosoma mansoni infection is controlled by a major locus that is closely linked to the interferon-gamma receptor gene
Am J Hum Genet
Mortality in chronic splenomegaly due to schistosomiasis mansoni: follow-up study in a Brazilian population
Trans R Soc Trop Med Hyg
The epidemiology and consequences of Schistosoma mansoni infection in West Nile, Uganda, II: hospital investigation of a sample from the Panyagoro community
Trans R Soc Trop Med Hyg
The changing face of schistosomal glomerulopathy
Kidney Int
Female genital schistosomiasis: fact and hypotheses
Acta Trop
Regauging the cost of chronic helminthic infection: meta-analysis of disability-related outcomes in endemic schistosomiasis
Lancet
Diagnostic techniques in schistosomiasis control: a review
Acta Trop
Underestimation of Schistosoma mansoni prevalences
Parasitol Today
Comparison of the direct faecal smear and two thick smear techniques for the diagnosis of intestinal parasitic infections
Trans R Soc Trop Med Hyg
Long seronegative window in schistosoma infection
Lancet
Screening for schistosomiasis with questionnaires
Trends Parasitol
Rapid screening method for Schistosoma japonicum infection using questionnaires in flood area of the People's Republic of China
Acta Tropica
Laparoscopic diagnosis and clinical course of chronic schistosomiasis japonica
Acta Trop
Schistosoma mansoni: assessment of morbidity before and after control
Acta Trop
The use of ultrasound in schistosomiasis
Adv Parasitol
Ultrasound in tropical and parasitic diseases
Lancet
Albendazole, mebendazole and praziquantel: review of non-clinical toxicity and pharmacokinetics
Acta Trop
An international initiative on praziquantel use
Parasitol Today
Global distribution of schistosomiasis: CEGET/WHO atlas
World Health Stat Q
Human schistosomiasis
Freshwater snails of Africa and their medical importance
Schistosomiasis
Curr Treat Options Infect Dis
Prevention and control of schistosomiasis and soil-transmitted helminthiasis. Technical report series
Schistosomiasis
N Engl J Med
Immunological aspects of schistosomiasis
Parasite Immunol
Health and irrigation. ILRI publication 45
Parasitic diseases and urban development
Bull World Health Organ
The distribution of Schistosoma mansoni in the Rusizi plain (Burundi)
Ann Trop Med Parasitol
Molluscan and vertebrate immune responses to bird schistosomes
Parasite Immunol
Schistosome dermatitis: an unrecognized problem in South Africa?
S Afr Med J
Acute schistosomiasis: clinical, diagnostic and therapeutic features
Rev Inst Med Trop Sao Paulo
Gastro-intestinal manifestations of the initial phase of schistosomiasis mansoni
Ann Trop Med Parasitol
Pulmonary manifestations in the initial phase of schistosomiasis mansoni
Rev Inst Med Trop Sao Paulo
B cell sensitization to helminthic infection develops in utero in humans
J Immunol
Schistosomiasis: an underestimated problem in industrialised countries?
J Travel Med
Schistosomiasis in travelers and expatriates
J Travel Med
Schistosoma japonicum and S japonicum-like infections: epidemiology, clinical and pathological aspects
Schistosomiasis in the People's Republic of China: prospects and challenges for the 21st century
Clin Microbiol Rev
Cited by (1737)
Schistosomiasis: A neglected cause of pulmonary arterial hypertension in Brazil
2024, Current Problems in CardiologyExploring the interplay between climate change and schistosomiasis transmission dynamics
2024, Infectious Disease ModellingChronic intestinal schistosomiasis caused by co-infection with Schistosoma intercalatum and Schistosoma mansoni
2024, The Lancet Infectious DiseasesBiology of Anemia: A Public Health Perspective
2023, Journal of Nutrition